Actively Recruiting
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population
Led by Novartis Pharmaceuticals · Updated on 2026-04-21
250
Participants Needed
8
Research Sites
145 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to generate real-world evidence to fill knowledge gaps regarding the response to secukinumab in patients with moderate to severe HS, its treatment patterns, the clinical characteristics of patients on secukinumab, healthcare resource utilization and the economic impact of HS in Italy.
CONDITIONS
Official Title
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female patients who provide written informed consent and privacy form to participate in the study
- Aged 18 years or older at consent
- Patients with moderate or severe hidradenitis suppurativa as assessed by investigators
- Start of secukinumab treatment within 30 days after consent, not treated with secukinumab before enrolment
- For healthcare resource use and economic burden analysis: patients who consent to use of secondary administrative data
- For healthcare resource use and economic burden analysis: patients with over 12 months residence in the local health unit area (only at certain sites)
You will not qualify if you...
- Participation in an ongoing clinical trial
- Any medical or psychological condition preventing study participation as decided by the practitioner
- For healthcare resource use and economic burden analysis: inability to identify patient in local health unit administrative databases at enrollment site
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 8 locations
1
Novartis Investigative Site
Ancona, AN, Italy, 60126
Actively Recruiting
2
Novartis Investigative Site
Brescia, BS, Italy, 25123
Actively Recruiting
3
Novartis Investigative Site
Florence, FI, Italy, 50122
Actively Recruiting
4
Novartis Investigative Site
Lecce, LE, Italy, 73100
Actively Recruiting
5
Novartis Investigative Site
Messina, ME, Italy, 98125
Actively Recruiting
6
Novartis Investigative Site
Rozzano, MI, Italy, 20089
Actively Recruiting
7
Novartis Investigative Site
San Donato Milanese, MI, Italy, 20097
Actively Recruiting
8
Novartis Investigative Site
Trento, TN, Italy, 38100
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here